An unexpected diagnosis in a patient with new-onset pulmonary infiltrates during adjuvant therapy for breast cancer.

Autor: Aguiar-Bujanda D; Department of Medical Oncology, Hospital Universitario de Gran Canaria Dr Negrin, c/ Barranco de la Ballena s/n, 35010 Las Palmas de Gran Canaria, Spain., Ros-Sanjuan L; Department of Medical Oncology, Hospital Universitario de Gran Canaria Dr Negrin, c/ Barranco de la Ballena s/n, 35010 Las Palmas de Gran Canaria, Spain., Hernandez-Sosa M; Department of Medical Oncology, Hospital Universitario de Gran Canaria Dr Negrin, c/ Barranco de la Ballena s/n, 35010 Las Palmas de Gran Canaria, Spain., Perera-Romero C; Department of Nuclear Medicine, Hospital Universitario de Gran Canaria Dr Negrin, c/ Barranco de la Ballena s/n, 35010 Las Palmas de Gran Canaria, Spain.
Jazyk: angličtina
Zdroj: Oxford medical case reports [Oxf Med Case Reports] 2018 Feb 09; Vol. 2018 (2), pp. omx095. Date of Electronic Publication: 2018 Feb 09 (Print Publication: 2018).
DOI: 10.1093/omcr/omx095
Abstrakt: The differential diagnosis of new-onset pulmonary infiltrates during adjuvant therapy in a cancer patient is challenging. Opportunistic infections, pulmonary drug-induced toxicity and metastatic dissemination of the underlying cancer are the most common causes. However, although infrequent, the development of a second primary pulmonary neoplasia should be taken into account. We present the clinical case of a breast cancer patient who developed progressive pulmonary infiltrates during adjuvant therapy, who was finally diagnosed as having a second lung neoplasm of unexpected histology.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje